ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Azenta at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Azenta brings 2 presentations to ASHG 2026 in Montréal. Its program centres on computational genetics and therapeutic discovery. Its presentations cover single-nuclei transcriptomic analysis of blood from PAXgene tubes and an AI-enabled platform for bispecific antibody discovery.

OrganizationASHG 2026 Attendance
Azenta
Burlington, Massachusetts
1 Director, US NGS & Clinical Services · 1 Business Process Manager, Azenta Life Sciences
Public company~2,900 people
Azenta sells sample-management systems, cold-chain storage, and LIMS software. It provides sequencing, gene synthesis, and sample-storage services to pharma, biotech, academic, and healthcare organizations.
Martin Madaus appointed interim CEO amid executive transition (2026-08)
›
Martin Madaus appointed interim CEO amid executive transition · 2026-08-24
“Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.”
Trey Martin appointed president of Multiomics business · 2026-04-07
“Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business”
Azenta acquires UK Biocentre to expand biorepository capabilities · 2026-03-04
“its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited”
Source: company newsroom
Q3 FY2026 revenue $161M, up 12%
›
Q3 FY2026 continuing-operations revenue was $161 million, up 12% year over year; FY2026 guidance was approximately $613-$618 million. · 2026-06-30
“"Revenue was $161 million, up 12% year over year"; "reported revenue from continuing operations to range approximately between $613 to $618 million"”
Source: results release
Poster
Wed Oct 21
2:30 pm
Utilizing blood from PAXgene tubes for single nuclei transcriptomic analysis
TranscriptomeSingle-cellTranslational studies and preclinical trialsGenomics
Poster
Thu Oct 22
4:15 pm
AI-Enabled High-Throughput Platform for Accelerated Bispecific Antibody Discovery
BioinformaticsCancerComputational toolsMachine learning

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Azenta

Tell us what you sell and we’ll find the people at Azenta most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction